Literature DB >> 31853978

Cyclin-dependent kinase 4 inhibits the translational repressor 4E-BP1 to promote cap-dependent translation during mitosis-G1 transition.

Dylan C Mitchell1, Arya Menon2, Amanda L Garner1,2.   

Abstract

Phosphorylation of translational repressor eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) controls the initiation of cap-dependent translation, a type of protein synthesis that is frequently upregulated in human diseases such as cancer. Because of its critical cellular function, it is not surprising that multiple kinases can post-translationally modify 4E-BP1 to drive aberrant cap-dependent translation. We recently reported a site-selective chemoproteomic method for uncovering kinase-substrate interactions, and using this approach, we discovered the cyclin-dependent kinase (CDK)4 as a new 4E-BP1 kinase. Herein, we describe our extension of this work and reveal the role of CDK4 in modulating 4E-BP1 activity in the transition from mitosis to G1, thereby demonstrating a novel role for this kinase in cell cycle regulation.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  4E-BP1; CDK4; cap-dependent translation; mitosis

Mesh:

Substances:

Year:  2019        PMID: 31853978      PMCID: PMC7188594          DOI: 10.1002/1873-3468.13721

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  69 in total

Review 1.  Regulation of cap-dependent translation by eIF4E inhibitory proteins.

Authors:  Joel D Richter; Nahum Sonenberg
Journal:  Nature       Date:  2005-02-03       Impact factor: 49.962

2.  mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.

Authors:  Yanjie Zhang; X F Steven Zheng
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

3.  Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism.

Authors:  A C Gingras; S P Gygi; B Raught; R D Polakiewicz; R T Abraham; M F Hoekstra; R Aebersold; N Sonenberg
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

Review 4.  Regulation of translation initiation by FRAP/mTOR.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

Review 5.  Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.

Authors:  Jerry Pelletier; Jeremy Graff; Davide Ruggero; Nahum Sonenberg
Journal:  Cancer Res       Date:  2015-01-15       Impact factor: 12.701

6.  PLK1 regulates spindle association of phosphorylated eukaryotic translation initiation factor 4E-binding protein and spindle function in mouse oocytes.

Authors:  Ashley L Severance; Keith E Latham
Journal:  Am J Physiol Cell Physiol       Date:  2018-02-22       Impact factor: 4.249

7.  CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation.

Authors:  Masahiro Shuda; Celestino Velásquez; Erdong Cheng; Daniel G Cordek; Hyun Jin Kwun; Yuan Chang; Patrick S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-16       Impact factor: 11.205

8.  Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.

Authors:  G S Ducker; C E Atreya; J P Simko; Y K Hom; M R Matli; C H Benes; B Hann; E K Nakakura; E K Bergsland; D B Donner; J Settleman; K M Shokat; R S Warren
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

9.  Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.

Authors:  Morris E Feldman; Beth Apsel; Aino Uotila; Robbie Loewith; Zachary A Knight; Davide Ruggero; Kevan M Shokat
Journal:  PLoS Biol       Date:  2009-02-10       Impact factor: 8.029

10.  Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma.

Authors:  Xinhua Song; Xianqiong Liu; Haichuan Wang; Jingxiao Wang; Yu Qiao; Antonio Cigliano; Kirsten Utpatel; Silvia Ribback; Maria G Pilo; Marina Serra; John D Gordan; Li Che; Shanshan Zhang; Antonio Cossu; Alberto Porcu; Rosa M Pascale; Frank Dombrowski; Hongbo Hu; Diego F Calvisi; Matthias Evert; Xin Chen
Journal:  Clin Cancer Res       Date:  2018-07-03       Impact factor: 13.801

View more
  1 in total

1.  Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors.

Authors:  Zijie Cai; Jingru Wang; Yudong Li; Qianfeng Shi; Liang Jin; Shunying Li; Mengdi Zhu; Qi Wang; Lok Lam Wong; Wang Yang; Hongna Lai; Chang Gong; Yandan Yao; Yujie Liu; Jun Zhang; Herui Yao; Qiang Liu
Journal:  Sci China Life Sci       Date:  2022-08-11       Impact factor: 10.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.